A positron emission tomography (PET) imaging study to investigate the biodistribution and clearance of an albumin binding domain antibody (AlbudAb) GSK3128349 in healthy male subjects

Trial Identifier: 117169
Sponsor: GlaxoSmithKline
Collaborator:
PRA Health Sciences for clinical study conduct.
Start Date: August 2016
Primary Completion Date: January 2017
Condition: Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
Dutch Version

Trial Locations

Country Location
Netherlands ZUIDLAREN, Netherlands, 9471 GP